Matthew Gavidia

Use of drugs commonly used to treat enlarged prostate was associated with a reduced risk of developing Parkinson disease in men.

Welfare recipients who were unable to meet their rent or mortgage payments were more likely to have impaired sleep duration and sleep quality, with those forced to move exhibiting more severe impairment.

A 9% year-over-year increase was observed in the number of US Medicare beneficiaries who enrolled in a Medicare Advantage health plan in 2020, with the increase in enrollment influenced by the coronavirus disease 2019 pandemic and its related effects.

Researchers find that a patient with depressive symptoms and cognitive impairment who did not respond to prior antidepressant medication showed marked improvement through continuous positive airway pressure (CPAP) therapy after being diagnosed with underlying severe obstructive sleep apnea.

Patients with symptomatic acute hepatic porphyria were found to be at greater risk of accessing long-term sick leave and disability pension compared with the general population, but were not shown to be at an increased overall risk of premature death.

Changes in blood pressure, percentage of red blood cells, and serum cholesterol levels were found to occur in patients with Parkinson disease before the onset of motor symptoms, suggesting potential biomarkers for early diagnosis and treatment.

Patients with narcolepsy type 1 who are working or studying from home amid the coronavirus disease 2019 pandemic exhibited an increase in nocturnal sleep time and reduced daytime sleepiness. These patients also presented with significant weight gain.

Black patients hospitalized with coronavirus disease 2019 from an urban academic medical center in New York City exhibited high rates of comorbidities and in-hospital mortality, with chronic obstructive pulmonary disease and asthma significantly linked with early death.

Among patients with long-term usage of continuous positive airway pressure (CPAP) therapy, several mask-related adverse effects were associated with CPAP nonadherence and residual excessive sleepiness.

Findings of the Change Healthcare 2020 Revenue Cycle Denials Index indicate that since the onset of the coronavirus disease 2019 (COVID-19) pandemic, medical claim denials have risen 11% nationwide, with the most denial rates found in regions with the highest first wave of outbreaks.

A stark 82% of assessed patients with hereditary transthyretin (ATTRv) amyloidosis exhibited at least 1 gastrointestinal symptom, warranting the need for gastroenterologists in multidisciplinary management of the disease.

The 62nd American Society of Hematology (ASH) Annual Meeting and Exposition featured leading experts in hematology and covered some of the most cutting-edge research in the field.

Obstructive sleep apnea was identified as an independent risk factor for severe coronavirus disease 2019 (COVID-19) resulting in hospitalization.

Machine learning identified patients with rheumatoid arthritis who may have an increased chance of achieving clinical response with sarilumab, with those selected also showing an inferior response to adalimumab.

Based on US health insurance consumer behavior reported in the eHealth Insights: 2020 Retrospective report, notable trends of the past year to watch for in 2021 include the popularity of $0 premium Medicare Advantage plans, the rise of telemedicine, and potential hesitancy against taking a vaccine for coronavirus disease 2019.

Focused ultrasound subthalamotomy was shown to improve motor features among patients with Parkinson disease who present with asymmetric symptom severity.

Among patients hospitalized with coronavirus disease 2019 (COVID-19) in Wuhan, China, fatigue and muscle weakness, as well as sleep difficulties, were shown to persist in more than 1 in 4 patients after 6 months.

Defective metabolism of levodopa in the brain was associated with a decline in the drug's efficacy over time and the adverse effect of dyskinesia among patients with Parkinson disease.

Among patients who have chronic obstructive pulmonary disease (COPD), the pathophysiology for disturbed sleep consists of physiological changes, ventilatory disturbances, and inflammation.

A recent study explored how patients with Parkinson disease who suffer from constipation are more likely to have other nonmotor symptoms than patients without constipation.

In recent clinical practice guidelines issued by the American Academy of Sleep Medicine (AASM), authors established recommendations for the use of behavioral and psychological treatments for chronic insomnia disorder in adults.

Patients with newly diagnosed Parkinson disease (PD) who carried mutations in the Parkin gene were found to exhibit worse quality of life, longer disease duration, and an earlier age at disease onset than those with PD who did not carry the mutation.

The top 5 most-read Parkinson disease stories of 2020 on AJMC.com included the latest insights on treatments such as spinal cord stimulation and the role of dietary management, as well as implications of the coronavirus disease 2019 pandemic.

In 2020, the top 5 most-watched interviews published on AJMC.com addressed a myriad of different issues within breast cancer, cardiology, and HIV, with additional perspectives on the coronavirus disease 2019 pandemic.

The top 5 most-read sleep stories of 2020 on AJMC.com spotlighted the role of sleep hygiene among children and adolescents, changes in sleeping habits amid the pandemic, and how a rare gene mutation may cause people to require less sleep to achieve wakefulness.

Tomatoes metabolically engineered to be enriched by the antiparkinsonian drug levodopa may provide a novel, cost-effective source of the drug for patients with Parkinson disease.

Researchers discuss recent insights on the relationship between sleep-disordered breathing (SDB) and atrial fibrillation (AF), particularly how proper SDB management can reduce the incidence, burden, and recurrence of AF.

Among patients with Parkinson disease, a positive history of essential tremor was found to be associated with slower progression of motor and nonmotor symptoms, with no impact observed on survival.

The top 5 most-read employer stories of 2020 on AJMC.com focused primarily on the role of the coronavirus disease 2019 pandemic on several issues affecting the workplace, including adverse mental health outcomes, leave-related concerns, and the rise of virtual care.

The National Comprehensive Cancer Network (NCCN) recommended zanubrutinib, approved by the FDA for the treatment of adult patients with mantle cell lymphoma, as a first-line and second-line therapy for treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).